首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1633559

心律調節器市場規模、佔有率和成長分析（按類型、技術、植入、應用、最終用戶和地區）- 產業預測，2025-2032 年

Pacemakers Market Size, Share, Growth Analysis, By Type, By Technology, By Implantability, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月11日 | 出版商:

SkyQuest | 英文 224 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球心律調節器市場規模價值 46.7 億美元，預計將從 2024 年的 48.4 億美元成長到 2032 年的 64.2 億美元，預測期內（2025-2032 年）的複合年成長率為 3.6%。

心血管設備市場正在經歷顯著成長，這得益於心血管疾病盛行率和相關管理成本的上升、政府的支持政策以及無導線和 MRI 安全型號等先進的心律調節器技術。心臟疾病仍是全球最大的死亡原因，預計到2030年心血管疾病的經濟負擔將超過1.44兆美元，對心臟起搏裝置的需求十分迫切。 COVID-19 大流行進一步強調了改善患者治療效果的必要性，因為許多感染者將出現心血管併發症。國家醫療服務體系 (NHS) 和醫療保險 (Medicare) 等優惠的報銷制度有利於促進市場准入。包括波士頓科學公司和美Medtronic在內的行業領導者已經推出了創新心律調節器，這些起搏器透過遠端監控系統等進步提供了更高的準確性、更好的患者控制，並得到了報銷計劃的支持。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較（2022-2024 年）

主要企業簡介

Medtronic（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Biotronik SE & Co. KG（Germany）
MicroPort Scientific Corporation（China）
LivaNova PLC（UK）
Lepu Medical Technology Co., Ltd.（China）
Osypka AG（Germany）
Oscor Inc.（USA）
Pacetronix（India）
Medico SpA（Italy）
Shree Pacetronix Ltd.（India）
Cordis, a Cardinal Health company（USA）
BIOTRONIK（Germany）
ELA Medical（France）
Vitatron（Netherlands）
Guidant Corporation（USA）
Intermedics Inc.（USA）

結論和建議

簡介目錄

Product Code: SQMIG35A2628

Global Pacemakers Market size was valued at USD 4.67 billion in 2023 and is poised to grow from USD 4.84 billion in 2024 to USD 6.42 billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032).

The cardiovascular device market is experiencing significant growth, driven by rising CVD prevalence and related management costs, supportive government policies, and advanced pacemaker technologies like leadless and MRI-safe models. As coronary heart disease remains a leading cause of global mortality, the financial burden of cardiovascular diseases is projected to surpass USD 1,044 billion by 2030, creating a pressing demand for cardiac pacing devices. The COVID-19 pandemic has further intensified the need for improved patient outcomes as many infected individuals also experience CVD complications. Favorable reimbursement structures like the NHS and Medicare boost market accessibility. Industry leaders, including Boston Scientific and Medtronic, are launching innovative pacemakers supported by reimbursement plans, enhancing precision and patient management through advancements like remote monitoring systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pacemakers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pacemakers Market Segmental Analysis

Global Pacemakers Market is segmented by Type, Technology, Implantability, Application, End User and region. Based on Type, the market is segmented into MRI Compatible Pacemaker and Conventional Pacemaker. Based on Technology, the market is segmented into Single-chamber Pacemaker, Dual-chamber Pacemaker and Biventricular/CRT Pacemaker. Based on Implantability, the market is segmented into Implantable Pacemaker and External Pacemaker. Based on Application, the market is segmented into Bradycardia, Acute Myocardial Infarction, Arrhythmias, Atrial Fibrillation, Heart Block, Long QT Syndrome, Non-Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospital, Cardiac Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pacemakers Market

The global pacemakers market is significantly driven by the rising aging population, which contributes to a heightened prevalence of age-related cardiovascular conditions. As individuals grow older, they become more susceptible to various heart rhythm disorders, resulting in a greater need for pacemaker devices. This demographic shift not only amplifies the demand for innovative cardiac solutions but also propels advancements in pacemaker technology. Consequently, healthcare providers are increasingly focused on addressing the specific needs of elderly patients, which further fuels the expansion of the pacemakers market worldwide. Thus, the intersection of aging demographics and cardiovascular health creates a substantial growth opportunity in this sector.

Restraints in the Global Pacemakers Market

Restraints in the global pacemakers market are predominantly influenced by the high costs associated with these devices. The overall expenses encompass not only the price of the pacemaker itself but also the surgical procedures required for implantation and the subsequent follow-up care. Such financial burdens can restrict accessibility, particularly in developing regions where healthcare budgets are limited. This affordability challenge can significantly impede the growth of the pacemakers market, as potential patients may be unable to obtain the necessary treatments and medical interventions, ultimately affecting market expansion and the potential reach of pacemaker technologies.

Market Trends of the Global Pacemakers Market

The Global Pacemakers market is experiencing a significant trend driven by ongoing technological advancements that enhance device functionality and patient care. Manufacturers are increasingly integrating features such as remote monitoring, which allows healthcare providers to track patient data in real-time, alongside wireless connectivity that streamlines communication. Additionally, the introduction of MRI-compatible pacemakers and innovations aimed at extending battery life further bolster market appeal. These advancements not only improve device performance but also elevate patient convenience and safety, fueling market growth as healthcare systems seek devices that meet evolving clinical needs and improve outcomes for patients with cardiac conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Pacemakers Market Size by Type & CAGR (2025-2032)

Market Overview
MRI Compatible Pacemaker
Conventional Pacemaker

Global Pacemakers Market Size by Technology & CAGR (2025-2032)

Market Overview
Single-chamber Pacemaker
Dual-chamber Pacemaker
Biventricular/CRT Pacemaker

Global Pacemakers Market Size by Implantability & CAGR (2025-2032)

Market Overview
Implantable Pacemaker
- Conventional
- Leadless
External Pacemaker

Global Pacemakers Market Size by Application & CAGR (2025-2032)

Market Overview
Bradycardia
Acute Myocardial Infarction
Arrhythmias
Atrial Fibrillation
Heart Block
Long QT Syndrome
Non-Congestive Heart Failure
Others

Global Pacemakers Market Size by End User & CAGR (2025-2032)

Market Overview
Hospital
Cardiac Clinics
Ambulatory Surgical Centers (ASCs)
Others

Global Pacemakers Market Size & CAGR (2025-2032)

North America (Type, Technology, Implantability, Application, End User)
- US
- Canada
Europe (Type, Technology, Implantability, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Technology, Implantability, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Technology, Implantability, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Technology, Implantability, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oscor Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacetronix (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordis, a Cardinal Health company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ELA Medical (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitatron (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guidant Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intermedics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments